In a mixed cohort of patients with both high and low risk PC treated with RP, including patients on TRT because of testosterone deficiency followed for 36 months, a PSA increase was observed in the TRT group, but with more biopsy verified PC-recurrences in the group without TRT [150]. The gene discussed is KLK3; the disease is pachyonychia congenita.